FIELD: biotechnology.
SUBSTANCE: invention relates to biotechnology, specifically to methods of treating a patient suffering from asthma, by selective introduction of the IL-13 antagonist, based on the fact that the patient is genetically predisposed to give a favorable response to the treatment with the IL-13 antagonist. Present document also describes diagnostic methods and kits which can be used to predict the probability that a patient suffering from asthma will respond to treatment with an IL-13 antagonist.
EFFECT: disclosed are methods for selective treatment of asthma using IL-13 antagonists.
21 cl, 4 dwg, 9 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| HUMAN GENETIC MARKERS ASSOCIATED WITH RESPONSE TO TREATMENT AGENTS THAT TARGET TOXIN B CLOSTRIDIUM DIFFICILE | 2017 |
|
RU2761249C2 |
| GENETIC MARKERS FOR PREDICTION OF SUSCEPTIBILITY TO THERAPY | 2014 |
|
RU2707533C2 |
| METHODS AND COMPOSITIONS FOR PREDICTION OF THERAPEUTIC EFFICIENCY OF TREATMENT OF ONCOLOGICAL DISEASES AND PREDICTION OF ONCOLOGICAL DISEASES | 2016 |
|
RU2785291C2 |
| ANALYSIS AND METHOD FOR TREATMENT REGIMEN SELECTION FOR PATIENTS WITH DEPRESSION | 2012 |
|
RU2622082C2 |
| THERAPEUTIC AND DIAGNOSTIC METHODS FOR MAST CELL-MEDIATED INFLAMMATORY DISEASES | 2019 |
|
RU2795180C2 |
| METHOD FOR DETERMINING HELICOBACTER PYLORI | 2017 |
|
RU2744190C1 |
| GENETIC TEST FOR COPPER ACCUMULATION IN LIVER IN DOGS | 2012 |
|
RU2707814C2 |
| GENETIC TEST FOR LIVER COPPER ACCUMULATION IN DOGS | 2012 |
|
RU2662660C2 |
| METHOD OF DIAGNOSING LUPUS IN HUMAN | 2010 |
|
RU2596391C2 |
| GENETIC TEST FOR ACCUMULATION OF COPPER IN DOGS' LIVER AND LOW-COPPER DOMESTIC ANIMAL FEED | 2010 |
|
RU2564129C2 |
